DermoSafe SA

DermoSafe is a full service-oriented tele-medical platform for early melanoma detection. A medical device, a web platform, and services

  • Stage Full Product Ready
  • Industry Business Products
  • Location Chemin des Cornalles, Corseaux, VD, Switzerland
  • Currency CHF
  • Founded November 2012
  • Employees 3
  • Website dermosafe.com

Company Summary

Our USP consists in our ability to deliver to patients through new channels a fast and precise access to melanoma diagnosis. The service is provided with the integration of an innovative & user-friendly medical device, a web-platform and a virtual competence centre. Melanoma represents a major new social health challenge. It is a lethal cancer if detected too late, but early detection can ensure recovery in 95% of cases.

Team

  • Philippe Held
    CEO & Founder

    Entrepreneur holding engineering degree in electroctechnics from the HES Yverdon Switzerland and a postgrade in management from the Union Technique Suisse (UTS).

  • Eugen Grecu
    Advisor & Co-founder & Co-Investor

    MD, Doctorarte in Medicine with a master in « Pharmaceutical Economics and Policies ». Wide international experience, executive management for 3 of the top 20 of pharmaceutical groups

  • Thierry Weber
    Director of Marketing/Coms & co-investor

    MD, Doctorate in Medicine, medical marketing/communications specialist. Broad experience in setting-upscreening and prevention campaigns. Member of the Faculty of the EMBA in healthcare management, Lausanne University Business School, Switzerland

  • Kim Rochat
    Director of Quality & Regulatory / co-investor

    Master MBA in Information security Management, Medical informatics, Economist HES. Specialist in medical regulation and certification

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free